Hyperthermia, a cancer treatment using controlled heat to kill tumor cells, shows promise but faces limitations due to some ...

Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...

Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with ...

U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support licensure Advisory Committee meeting scheduled for July 30, 2025 Mid-cycle ...

Breast cancer remains the most prevalent malignancy among women worldwide, posing a critical challenge to global health.

The stem cell-based embryo model (SCBEM) takes advantage of the flexibility of pluripotent stem cells (non-reproductive cells ...

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and ...

Conventional transcriptomic techniques have revealed much about gene expression at the population and single-cell level—but ...

The FDA has granted fast track designation to Amylyx's experimental therapy AMX0114 for the treatment of amyotrophic lateral ...

A 60-year-old anesthetic is rewiring traumatized brains in hours, not months. Could this change everything for millions ...

We are thrilled that the FDA has recognized the unmet needs in the chronic neutropenia community and granted us Fast Track designation for mavorixafor for the treatment of CN,” said Christophe ...